Chronic Kidney Disease Flashcards

1
Q

CKD is defined as __ (eGFR __) for (duration)

A

kidney damage or reduced kidney function (eGFR <60) for 3 or more months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the markers of CKD?

A
  1. Albuminuria woth ACR > 30mg/g
  2. Urine sediment abnormalities
  3. Electrolyte imbalance due to tubular disorders
  4. Histologic abnormalities
  5. Structural abnormalities on imaging
  6. History of kidney transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

KDIGO Classification of CKD:
CKD secondary to (Cause), stage (GFR stage) - (ACR stage)

Prognosis of CKD by GFR-ACR categories

A

Comparative albuminuria staging for proteinuria
A1: uPCR < 15 mg/mmol or protein strip trace
- Protein excretion rate < 150 mg/1.73m2/day

A2: uPCR 15-50 mg/mmol or protein stip trace to 1+
- Protein excretion rate 150 - 500 mg/1.73m2/day

A3: uPCR > 50 mg/mmol or protein strip 2+
- Protein excretion rate > 500 mg/1.73m2/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Importance of early identification of CKD

A
  1. Definitive diagnosis
  2. Treatment to prevent progression
  3. Managment of CKD complications
    - Anaemia, mineral bone disease, acidosis, cardiovascular diseases
  4. Prevent and detect further AKI
  5. Plan for RRT or transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the factors that influence serum creatinine levels?

A

Increased production
1. Muscle mass
2. Protein intake (myotein intake)

Reduced excretion
3. CKD
4. Drugs
- trimethoprim, fenofibrate
- NSAIDs (unapposed renal afferent arteriole vasoconstriction)
- SGLT2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is it important to evaluate urinary albumin excretion in CKD?

A

Albuminuria as risk factor for development of ESRF
(Nephrotic range proteinuria higher risk)

Reduction in proteinuria is associated with improved kidney outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the causes of CKD?
(Bolded are commonest)

A

Glomerular
- FSGS - primary or secondary
> Secondary FSGS: DM, HTN
- IgAN
- Membranous nephropathy
- Diffuse proliferative GN
- MCD

Tubulointerstitial
- UTI
- Autoimmune
- Stones
- Obstruction

Vascular
- ANCA associated vasculitis
- Fibromuscular dysplasia

Cystic and congenital
- Kidney dysplasia
- Medullary cystic disease
- Polycystic kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Do all diabetic patients develop CKD?
How to diagnose CKD-DKD?
When is it indicated for renal biopsy?

A

Only 30-40% type 1 or type 2 DM develop CKD

Presumed DM nephropathy in patients with:
DM + albuminuria + DM complications

Indications for renal biopsy in DM patients:
- RBC cast
- Nephropathy early in course of DM
- Rapid progression of CKD
(Caution: some studies have shown that half of type 2 DM patient actually has CKD from other diseases instead of DM nephropathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

African patients have higher incidence of CKD due to __.
__ gene on chromosome 22q13 greatly increases CKD risk,

Advantage: confers ability to kill __ to provide survival advantage in endemic areas.
Disadvantages: associated CKD diseases (3)

A

Familial aggregation of ESRF
APOL1 gene
Ability to kill trypanosoma brucei rhodesiense

Associated with:
1. Idiopathic FSGS
2. HIV associated nephropathy
3. Hypertensive nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the risk factors for developing CKD?

A

Non-modifiable
- Age (natural eGFR reduction of 1 point per year)
- Family history of kidney disease
- Low birth weight
- Ethnicity (African)
- Reduction in kidney drugs

Modifiable
- Diabetes mellitus
- Hypertension
- Smoking
- Obesity and metabolic syndrome
- Cardiovascular disease
- Autoimmune disease - SLE
- AKI and its recovery
- UTI with reflux nephropathy
- Kidney stones
- LUT obstruction
- Nephrotoxic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does kidney disease progress?

A
  1. Initial adaptive changes to loss of nephrons
    - Glomerular hyperfiltration
    - Increased residual nephrons filtration rate
  2. Pathologic changes
    - Glomerular sclerosis
    - Kidney fibrosis
    - Podocytes loss
    - RAS activation
    - Proteinuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the common symptoms of CKD

A
  1. Fatigue
  2. Weakness
  3. Anorexia
  4. Nausea, vomiting
  5. Volume overload with pulmonary oedema
  6. Pericarditis
  7. Peripheral neuropathy
  8. Seizures, coma, death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the pathology of diabetic nephropathy

A
  1. Glomerular and tubular basement membrane thickening
  2. Mesangial expansion forming nodules (Kimmelstiel-Wilson lesion)
  3. Arteriolar hyalinosis
  4. Tubulointerstitial fibrosis

Glucose toxicity
Glomerular hypertension
Oxidative stress
Toxic effects of metabolites, cytokines
Advanced glycation end products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the complications of CKD?

A
  1. Volume overload
  2. Hyperkalaemia
  3. Metabolic acidosis
  4. Hyperphosphataemia
  5. Hypertension
  6. Anaemia
  7. Malnutrition
  8. Mineral bone disease
  9. Dyslipidaemia
  10. Sexual dysfunction
  11. Uraemic bleeding
  12. Recurrent infection
  13. Pericarditis
  14. Uraemic encephalopathy
  15. Thyroid dysfunction
  16. Cardiovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Slowing down progression of CKD

A
  1. BP control
  2. RAS inhibition
  3. Dietary protein restriction
  4. Good glycaemic control
  5. Bicarbonate supplementation if Bicarb < 22
  6. Avoid nephrotoxic drugs - NSAIDs, aminoglycosides, contrast
  7. Treat reversible causes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When to refer to Nephrologist?

A
  1. eGFR < 30
  2. Urine ACR > 300mg/g
17
Q

Management of AF in CKD
- SPAF-3 trial
- Approved anticoagulants for ESRF

A

SPAF-3 trial
Warfarin reduces risk of stroke in CKD 3A to 3B
No strong evidence in advanced CKD
High risk of ICH or GI bleed due to platelet dysfunction, anaemia, enthelial and vascular dysfunction

HAS-BLED score is not formally validated in advanced CKD

Approved anticoagulants for ESRF
1. Warfain
2. Apixaban at 2.5mg BD (only in USA, not worldwide)
(Other DOACs are not approved - off label use)

18
Q

What are the renal clearance for oral anticoagulants?
As such what is the dose adjustment for oral anticoagulants?

A
19
Q

Cholesterol embolism with intra-arterial procedure

A

Following vascular or coronary intra-arterial procedure, cholesterol embolism may develop and cause:

  • Progressive and irreversible loss of kidney function, over days and weeks
  • Features: livedo reticularis, distal emboli to digits or retina
  • Investigations: low complements, eosinophilia and eosinophiluria
20
Q

Management of hyperlipidaemia in CKD
- Study of Heart and Renap Protection study (SHARP)

A

SHARP study
- CKD with simvastatin/ezetimibe associated with significant reduction in cardiovascular event
- No effect on mortality
- Benefit of lipid lowering agents in CKD not as robust as without CKD

21
Q

Proteinuria reduction and Cardiovascular risk

A

Reduction in urine protein excretion is associated with: -
- Long term slowing kidney function loss
- However unclear on cardiovascular risk

Management:
1. Targeted therapy for underlying disease
2. ACEi or ARB

Target: reduction of proteinuria to < 1 g/day

22
Q

Management of blood pressure in CKD
- Systolic Blood Pressure Intervention Trial (SPRINT)

A

SPRINT Trial
- Target SBP < 120
- Associated with 25% lower risk of MI, ACS, stroke, heart failure or death from cardiovascular cause
- With and without kidney disease

  • Pending: rate of loss of kidney function as of 2024